Table III.
Multivariate survival analysis of independent prognostic factors by the Cox proportional hazard model in patients with NSCLC.
| Clinicopathological variable | B | SE | Wald | P-value | HR | 95% CI |
|---|---|---|---|---|---|---|
| Smoking history | −0.066 | 0.132 | 0.249 | 0.618 | 0.936 | 0.722~1.214 |
| Lesion type | −0.087 | 0.135 | 0.412 | 0.521 | 0.917 | 0.703~1.195 |
| Resection type | 0.138 | 0.163 | 0.717 | 0.397 | 1.148 | 0.834~1.579 |
| T stage | 0.033 | 0.095 | 0.119 | 0.730 | 1.033 | 0.858~1.244 |
| Lymph node metastasis | 0.754 | 0.118 | 41.020 | <0.001 | 2.125 | 1.687~2.676 |
| Fibrinogen level | 0.299 | 0.132 | 5.119 | 0.024 | 1.348 | 1.041~1.746 |
| D-dimer | 0.238 | 0.123 | 3.775 | 0.058 | 1.269 | 0.998~1.614 |
| NLR | 0.295 | 0.134 | 4.858 | 0.028 | 1.344 | 1.033~1.747 |
| PLR | 0.044 | 0.132 | 0.112 | 0.738 | 1.045 | 0.806~1.355 |
| LMR | −0.085 | 0.128 | 0.437 | 0.509 | 0.919 | 0.715~1.181 |
NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; LMR, lymphocyte-monocyte ratio; HR, hazard ratio; CI, confidence interval. Multivariate survival analysis with Cox regression model was used to calculate P-values.